Michael S Weiss's Net Worth
$553 Million
Who is Michael S Weiss?
Michael S Weiss has an estimated net worth of $553 Million. This is based on reported shares across multiple companies, which include TG THERAPEUTICS, INC., NATIONAL HOLDINGS CORP, Fortress Biotech, Inc., XTL BIOPHARMACEUTICALS LTD, AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., Checkpoint Therapeutics, Inc., GENTA INC DE/, CB Pharma Acquisition Corp., KERYX BIOPHARMACEUTICALS INC, and ROBECO SAGE TRITON FUND LLC.
SEC CIK
Michael S Weiss's CIK is 0001038977
Past Insider Trading and Trends
2006 was Michael S Weiss's most active year for acquiring shares with 16 total transactions. Michael S Weiss's most active month to acquire stocks was the month of November. 2006 was Michael S Weiss's most active year for disposing of shares, totalling 183 transactions. Michael S Weiss's most active month to dispose stocks was the month of November. 2014 saw Michael S Weiss paying a total of $1,610,000.00 for 5,227,295 shares, this is the most they've acquired in one year. In 2014 Michael S Weiss cashed out on 210,618 shares for a total of $3,462,559.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NATIONAL HOLDINGS CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TG THERAPEUTICS, INC. (TGTX) Snapshot price: $22.97
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.30% | 1M |
—
|
—
| 13.07M |
Jan 6
| |||
Form 4
| +0.84% | 100K |
$10.13 | $1,013,000.00 | 12.07M |
Aug 11
| |||
Form 4
| +8.96% | 985K |
—
|
—
| 11.97M |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| -2.88% | -723.83K |
$18.76 | -$1,282,526.81 | 24.44M |
Dec 15 - Jan 5
| |||
Form 4
| +8.27% | 1.08M |
—
|
—
| 14.15M |
Jun 18
| |||
Form 4
| +12.08% | 1.56M |
—
|
—
| 14.43M |
Jun 22
| |||
Form 4
| +0.39% | 50K |
$7.04 | $351,750.00 | 12.88M |
Jun 26
| |||
Form 4
| +10.12% | 1.18M |
—
|
—
| 12.83M |
Jun 13
| |||
Form 4
| +9.58% | 1.02M |
—
|
—
| 11.65M |
Jun 26
| |||
Form 4
| +2.43% | 484.88K |
—
|
—
| 20.43M |
Jun 19
| |||
Form 4
| +2.03% | 690.25K |
—
|
—
| 34.71M |
Dec 30 - Jan 1
| |||
Form 4
| -3.36% | -328.76K |
—
|
—
| 9.46M |
Sep 1
| |||
Form 4/A
| +7.70% | 672.34K |
—
|
—
| 9.4M |
Dec 31
| |||
Form 4
| +251.29% | 6.72M |
—
|
—
| 9.4M |
Dec 31
| |||
Form 4
| +4.02% | 337.26K |
—
|
—
| 8.73M |
Jun 4
| |||
Form 4
| +3.31% | 268.6K |
—
|
—
| 8.39M |
Dec 30
| |||
Form 4
| -2.53% | -210.62K |
$16.44 | -$3,462,559.92 | 8.12M |
Dec 16
| |||
Form 4
| +6.27% | 491.92K |
—
|
—
| 8.33M |
Dec 30
| |||
Form 4
| +0.13% | 10K |
$3.43 | $34,300.00 | 7.84M |
Dec 11
| |||
Form 4
| +6.63% | 486.74K |
—
|
—
| 7.83M |
Dec 28
| |||
Form 4
| +2.09% | 150K |
$2.25 | $337,500.00 | 7.34M |
Sep 10 - Sep 11
| |||
Form 4
| +3,015.61% | 5.03M |
$6.25 |
—
| 5.19M |
Apr 30 - May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fortress Biotech, Inc. (FBIO) Snapshot price: $1.79
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.15% | 216.47K |
—
|
—
| 1.35M |
Jan 1
| |||
Form 4
| +14.95% | 147.06K |
$1.70 | $249,998.60 | 1.13M |
Nov 14
| |||
Form 4
| +8.84% | 1.2M |
$0.84 | $999,999.34 | 14.75M |
Feb 10
| |||
Form 4
| +9.88% | 1.22M |
—
|
—
| 13.55M |
Jan 1
| |||
Form 4
| +9.82% | 1.1M |
—
|
—
| 12.34M |
Jan 1
| |||
Form 4
| +10.10% | 1.03M |
—
|
—
| 11.23M |
Jan 1
| |||
Form 4
| +8.53% | 801.54K |
—
|
—
| 10.2M |
Jan 1
| |||
Form 4
| +17.49% | 1.4M |
—
|
—
| 9.4M |
Jan 1 - Jan 1
| |||
Form 4
| +7.42% | 552.7K |
—
|
—
| 8M |
Jan 1
| |||
Form 4
| +7.36% | 510.43K |
—
|
—
| 7.45M |
Jan 1
| |||
Form 4
| +16.84% | 1M |
$1.61 | $1,610,000.00 | 6.94M |
Nov 6
| |||
Form 4
| +200.00% | 3.96M |
—
|
—
| 5.94M |
Feb 20
| |||
Form 4
|
∞
| 1.98M |
—
|
—
| 1.98M |
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XTL BIOPHARMACEUTICALS LTD (XTLB) Snapshot price: $2.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30 - Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $2.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +146.63% | 14.66K |
—
|
—
| 24.66K |
Aug 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||